Dupilumab for COPD | NEJM
293
0
2023-12-5 17:11
【悩む人多数】ばち指の見分け方3選【原因疾患も解説】
【40分で初心者を卒業】COPDの完全講義
8th TU Chest day #30minPCCM#ChestTU #TB #pneumothorax #CXR #ILD #COPD #parasitic #HFNC #OSA #MV
COPDの呼吸困難をストローで疑似体験してみる動画
【改善】失敗しない吸入器の選び方【喘息/COPD】
Practical solution of COPD treatment 3rd TU-ed (EP.4)
Innere Medizin ─ COPD
COPD常用治疗药物及注意事项
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
Some patients with COPD have type 2 inflammation, which may increase exacerbation risk. Dupilumab, a monoclonal antibody, targets type 2 inflammatory cytokines.
New research findings are summarized in a short video.
To see the full article, follow this link: https://nej.md/3Mkskdy
Comments 0
Please to post a comment~
Loading...
Related Suggestion